Jaguar Health JAGX
NASDAQ JAGX
$3.95 -0.55 (-12.22%)
At close: Oct 1, 2026 · 4:00 PM EDT

Jaguar Health (JAGX) Liabilities and Shareholders Equity (2014 - 2026)

Updated

Jaguar Health (JAGX) posted Liabilities and Shareholders Equity of $34.19 million for Q2 2026, down 29.2% from $48.27 million a year earlier and down 8.7% from the prior quarter.

Analysis

Jaguar Health (JAGX) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

At the end of FY2025, Jaguar Health's Liabilities and Shareholders Equity came in at $38.32 million, down 28.3% from FY2024.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -2.2% (FY2020 to FY2025).
  • In prior years, Jaguar Health's Liabilities and Shareholders Equity was $53.43 million in FY2024 (+5.2%), $50.76 million in FY2023 (+7.0%), $47.45 million in FY2022 (-10.9%) and $53.27 million in FY2021 (+24.3%).
  • The Q2 2026 figure stands as the lowest quarterly Liabilities and Shareholders Equity since Q1 2020.
  • On a year-over-year basis, Liabilities and Shareholders Equity has declined in each of the last six quarters, with an average decline of 11.8% over the last eight quarters.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q3 2021, with growth of 63.5%; the weakest was Q2 2026, with a decline of 29.2%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $37.43 million (Q1 2026), $38.32 million (Q4 2025) and $49.47 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Jaguar Health 720,234.00 -16.53 Mn 194,000.00 34.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.19 Mn
Mar 31, 2026 37.43 Mn
Dec 31, 2025 38.32 Mn
Sep 30, 2025 49.47 Mn
Jun 30, 2025 48.27 Mn
Mar 31, 2025 51.46 Mn
Dec 31, 2024 53.43 Mn
Sep 30, 2024 58.47 Mn
Jun 30, 2024 61.46 Mn
Mar 31, 2024 55.39 Mn
Dec 31, 2023 50.76 Mn
Sep 30, 2023 45.38 Mn
Jun 30, 2023 52.17 Mn
Mar 31, 2023 56.93 Mn
Dec 31, 2022 47.45 Mn
Sep 30, 2022 51.29 Mn
Jun 30, 2022 49.89 Mn
Mar 31, 2022 52.91 Mn
Dec 31, 2021 53.27 Mn
Sep 30, 2021 59.26 Mn
API Access

Jaguar Health Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=JAGX&period=max&api_key=YOUR_API_KEY